Innovation in proton therapy was front-and-centre at the ASTRO Annual Meeting, along with advances in other cutting-edge modalities – among them MR-guided adaptive radiotherapy, combined immunotherapy–radiotherapy approaches and stereotactic treatments for oligometatastic disease. Joe McEntee reports
Proton therapy on an upward trajectory while FLASH treatment schemes get ready to shine
24 Oct 2023
Joe McEntee is a consultant editor based in South Gloucestershire, UK